New breast cancer drug2nd October 2012
A new type of breast cancer medication which combines the drug Herceptin with a chemotherapy drug could extend the lives of women with HER-2 positive breast cancer by six months.
The drug T-DM1, which is made by Roche, can destroy cancer cells without causing too much damage to healthy cells. Paul Ellis, professor of cancer medicine at King’s College London, said: "HER-2 positive breast cancer is very aggressive and once it progresses to the “advanced” stage it becomes very difficult to treat. These results are truly outstanding and will positively alter the outlook and outcomes for patients."
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: New breast cancer drug
Author: Jess Laurence
Article Id: 22844
Date Added: 2nd Oct 2012